Serial #88787463
LIVE

Serial Number

88787463

Owner

Heritage Pharmaceuticals Inc.

Attorney

Matthew A. Homyk

First Use Date

Jan 29, 2020

Filing Date

Feb 6, 2020

Add to watchlist:

No watchlists yet
View on USPTO

Serial #88787463 Trademark

Serial Number: 88787463 • Registration: 6140677

Serial #88787463 is a trademark filed by Heritage Pharmaceuticals Inc. on February 6, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Heritage Pharmaceuticals Inc. (27 trademarks)

Suite 204
Edison, NJ 08837

Entity Type: 03

Trademark Details

Filing Date

February 6, 2020

Registration Date

September 1, 2020

First Use Anywhere

January 29, 2020

First Use in Commerce

January 29, 2020

Published for Opposition

June 16, 2020

Goods & Services

Custom manufacture of pharmaceuticals for others; providing technical information in the field of pharmaceutical manufacturing

Pharmaceutical preparations for the treatment of neurological, renal, hematopoietic, thyroid, and ophthalmic diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Anti-inflammatory pharmaceutical preparations; Cardiovascular pharmaceuticals; anti-microbial pharmaceutical preparations; anti-neoplastic pharmaceutical preparations; immunomodulatory pharmaceutical preparations; hematopoietic pharmaceutical preparations; Pharmaceutical preparations, namely, anticoagulants; pharmaceutical preparations, namely, thrombolytic agents; antiplatelets, namely, platelet agglutination inhibitors and platelet aggregation inhibitors; Estrogen preparations; pharmaceutical preparations, namely, progestin; Androgen preparations; Antithyroid pharmaceutical preparations used to treat hyperthyroidism; Pharmaceutical preparations for treating diabetes; pharmaceutical preparations, namely, histamine H2 receptor antagonists and proton pump antagonists; anti-emetic pharmaceutical preparations; anti-convulsant pharmaceutical preparations; pharmaceutical preparations for the treatment of asthma; anti-diabetic pharmaceuticals

Development of pharmaceutical preparations and medicines

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Sep 1, 2025 REM1
REGISTERED-PRINCIPAL REGISTER
Sep 1, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 16, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jun 16, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 27, 2020 NONP
ASSIGNED TO LIE
May 11, 2020 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 30, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 30, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 30, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 30, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 30, 2020 CNEA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Apr 29, 2020 GPRN
PRIORITY ACTION E-MAILED
Apr 29, 2020 GPRA
PRIORITY ACTION WRITTEN
Apr 29, 2020 CPRA
ASSIGNED TO EXAMINER
Apr 27, 2020 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Feb 11, 2020 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 10, 2020 NWOS
NEW APPLICATION ENTERED
Feb 10, 2020 NWAP